ESC Professional Premium Access

Lipids 2

Event: ESC Congress 2022
Topic: Lipids
Session type: Moderated ePosters
Date: 27 August 2022
Time: 11:15 - 12:00

Congress Session

6 presentations in this session

Simulated intervention and optimal timing for attenuating dyslipidaemia-related atherosclerotic progression in the young: a temporal inverse allocation analysis of the ALSPAC cohort

Speaker: Doctor A. Agbaje (Kuopio, FI)
Thumbnail

Elevated levels of Lp(a) are associated with coronary lesion complexity in patients hospitalized for an acute myocardial infarction: data from the French RICO Survey

Speaker: Doctor M. Kouame (Abidjan, CI)
Thumbnail

Association of propionate with coronary artery disease in a large cross-sectional study

Speaker: Professor N. Pagonas (Brandenburg, DE)
Thumbnail

Potential barriers in lipid-lowering treatment with PCSK9 inhibitors from a healthsystem perspective. Comparative evidence from ten countries.

Speaker: Doctor E. Apostolou (London, GB)
Thumbnail

Evaluation of the effects of immunization against PCSK9 on selected microRNAs involved in cholesterol homeostasis.

Speaker: Professor M. Banach (Lodz, PL)
Thumbnail

Realistic approach to evaluate the effect of baseline lipid profile in post cardiac surgery: Restricted Cubic Spline model

Speaker: Doctor A. Sheikhy (Tehran, IR)
Thumbnail

6 speakers from this session

Doctor Andrew O Agbaje

University of Eastern Finland, Kuopio (Finland)
0 follower

Doctor Miwakan Isabelle Macoucou Kouame

Abidjan Institute of Cardiology, Abidjan (Côte d'Ivoire)
0 follower

Professor Nikolaos Pagonas

University Hospital Brandenburg, Brandenburg (Germany)
0 follower

Doctor Efstratios Apostolou

LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)
4 presentations
1 follower

Doctor Ali Sheikhy

Tehran Heart Center, Tehran University of Medical Sciences, Tehran (Iran (Islamic Republic of))
0 follower

This platform is supported by

logo Novo Nordisk